Barno Alimova

Prof. Barno Alimova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2023 in Acta Scientiarum. Biological Sciences
Verified
Journal Article
Open access
PDF file
BABarno Alimova
Barno Alimova
OPOzodakhon Pulatova
Ozodakhon Pulatova
AMAkhmadjon Makhsumkhanov
Akhmadjon Makhsumkhanov
LKLobar Khasanova
Lobar Khasanova
KDKakhramon Davranov
Kakhramon Davranov
This article provides a study of the molecular, physiological, biochemical and morphological features of R-, S- and M-dissociants of Rhodococcus ruber - 8/4/1. The sequence similarity of the genome fragments of R- and S-dissociant forms encoded by 16S rRNA was demonstrated. MALDI spectra were obtained for the R. ruber-8/4/1 strain and its dissociants. Under standard analysis conditions, the MALDI profiles of R-, S- and M- forms dissociants of the Rhodococcus ruber - 8/4/1 were similar. The determination of the resistance of the strain dissociants to external factors showed that R-forms were more stable under UV irradiation and increased temperature. The S-forms showed stability upon the conversion of acrylic acid nitrile into acrylamide (AA), whereas the M-forms were stable under a decrease in the cultivation temperature, and an increase in the concentration of NaCl in the medium. The S-forms proved to be the most active in the transformation of acrylonitrile into AA.

18 May 2026 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
ISI.M. Saidova
I.M. Saidova
BABarno Alimova
Barno Alimova
DAD.A. Amirsaidova
D.A. Amirsaidova
GBG.A. Bekmurodova
G.A. Bekmurodova
SMShakhlo Miralimova
Shakhlo Miralimova
MMM.A. Makhsumxanova
M.A. Makhsumxanova
This study reports the characterization of Pediococcus acidilactici strain K1–UzRSMMT-396, a biosurfactant (BS)-producing lactic acid bacterium isolated from the traditional fermented milk product qurt. Primary screening of lactic acid bacteria isolates revealed a strain with pronounced surface-active properties, indicating its potential as a BS producer. Species identification was confirmed using morphological, biochemical, and molecular approaches, including MALDI-TOF MS and full-length 16S rRNA gene sequencing. The strain exhibited susceptibility to most of the tested antibiotics, including chloramphenicol, erythromycin, amikacin, cefotaxime, vancomycin, streptomycin, and amoxicillin/clavulanate, while showing moderate resistance to ciprofloxacin. P. acidilactici K1–UzRSMMT-396 demonstrated tolerance to simulated gastrointestinal conditions. After 90 min of exposure to simulated gastric juice (pH 2.0), viable cell counts remained at 5.1 ± 0.04 log CFU/mL, indicating the survival of a substantial fraction of the initial population. In the presence of bile salts, the strain maintained high viability, suggesting tolerance to conditions mimicking the small intestinal environment. In addition, the strain exhibited osmotolerance, retaining viability at elevated NaCl concentrations in MRS medium. Optimization of the cultivation medium showed that reducing cheese whey concentration from 50%-30% and halving the amounts of glucose, yeast autolysate, and ammonium citrate enhanced BS production. The emulsification index after 24 hrs of cultivation (EI24) reached 70%-74%, and the maximum BS yield was 2.704 g/L. The isolated biosurfactant exhibited pronounced antimicrobial activity against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, and effectively disrupted P. aeruginosa biofilms, resulting in a 59%-67% reduction in biofilm biomass depending on the test strain. These findings indicate that P. acidilactici strain K1–UzRSMMT-396 and its biosurfactant have strong potential for application in the food and pharmaceutical industries as safe antimicrobial and anti-adhesive agents.

16 July 2026 in Applied Microbiology
Verified
Journal Article
Open access
PDF file
BABarno Alimova
Barno Alimova
SISaidova Iroda
Saidova Iroda
MMMakhsumkhanova Mubinakhon
Makhsumkhanova Mubinakhon
BGBekmurodova Gullola
Bekmurodova Gullola
SMSayliev Mirshod
Sayliev Mirshod
ABAbdraimova Barno
Abdraimova Barno
The development of alternative strategies for gluten detoxification represents an important approach for the management of celiac disease and other gluten-related disorders. This study aimed to identify gluten-degrading Bacillus strains with probiotic potential by integrating enzymatic screening with comprehensive biosafety and functional characterization. A total of 45 isolates obtained from diverse ecological niches in Uzbekistan were evaluated for glutenolytic activity using an agar diffusion assay. Fifteen strains demonstrated detectable gluten hydrolysis (16–32 mm). The highest activity was observed in Bacillus cereus isolates (up to 32 mm), whereas Bacillus amyloliquefaciens and Bacillus licheniformis exhibited moderate activity (16–24 mm). However, biosafety profiling revealed pronounced hemolytic, lecithinase, and DNase activities in most B. cereus strains, along with reduced antibiotic susceptibility, which precludes their probiotic application. In contrast, B. amyloliquefaciens and B. licheniformis strains exhibited γ-hemolysis, lacked lecithinase and DNase activities, showed high susceptibility to clinically relevant antibiotics, and demonstrated satisfactory tolerance to simulated gastrointestinal conditions. None of the strains demonstrated detectable antimicrobial activity under standard in vitro conditions. Culture supernatants exhibited pronounced antioxidant activity (73.38–90.34% DPPH radical scavenging), indicating the production of extracellular bioactive metabolites. The results demonstrate functional divergence within the Bacillus genus between maximum glutenolytic capacity and probiotic safety. Species belonging to the Bacillus group, including Bacillus amyloliquefaciens, B. subtilis, and B. licheniformis, are widely recognized as safe for food and probiotic applications (GRAS and/or QPS when appropriately characterized at the strain level). Accordingly, while B. cereus strains represent promising sources of industrial gluten-degrading enzymes. B. amyloliquefaciens 6/4/2, together with selected B. subtilis and B. licheniformis strains, demonstrated the most favorable balance between glutenolytic activity and biosafety, making them the most promising candidates for further probiotic development.